Evidence map›Paper›PMID 35948387›Full record

ArticleBMJ open quality2022

Improving viral load utilisation to enhance care for Kenyan adolescents with HIV.

Gillian Dougherty, Steve Akoth, Mark Hawken, Isaac Leting, Redempta Mutei, Catherine Ngugi, Doris Naitore, Fatima Tsiouris, Anne Wakoli, Lauren Walker and 1 more

Abstract read
In one paragraph

Article in BMJ open quality, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Gillian DoughertyICAP at Columbia University, Mailman School of Public Health, New York, New York, USA gd2410@columbia.edu.ORCID 0000-0002-9199-958X
Steve AkothICAP Kenya, Nairobi, Kenya.
Mark HawkenICAP Kenya, Nairobi, Kenya.
Isaac LetingICAP Kenya, Nairobi, Kenya.
Redempta MuteiICAP Kenya, Nairobi, Kenya.
Catherine NgugiNational AIDS and STI Control Program, Nairobi, Kenya.
Doris NaitoreICAP Kenya, Nairobi, Kenya.
Fatima TsiourisICAP at Columbia University, Mailman School of Public Health, New York, New York, USA.
Anne WakoliICAP Kenya, Nairobi, Kenya.
Lauren WalkerICAP at Columbia University, Mailman School of Public Health, New York, New York, USA.
Miriam RabkinICAP at Columbia University, Mailman School of Public Health, New York, New York, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Improving the use of viral load (VL) testing for adolescents and young people living with HIV (AYPLWH) is a priority for Kenya's Ministry of Health (MOH). Despite expansion of VL testing coverage and rollout of national policies, guidelines and training, VL result utilisation for AYPLWH remains suboptimal, with inadequate adherence to national guidelines recommending everyone on antiretroviral therapy (ART) with unsuppressed viral load (UVL) (≥401 copies/mL) receive three enhanced adherence counselling (EAC) sessions and a repeat VL test within 3 months. In March 2019, ICAP at Columbia University partnered with the MOH to launch a Quality Improvement Collaborative (QIC) at 22 health facilities in the Eastern Province to optimise management of AYPLWH on ART with UVL. Over 17 months, facility QI teams tested interventions targeting client education, workflow modifications, commodity management, community engagement and improved documentation. The QIC led to marked improvement in the proportion of clients completing three EAC sessions and repeat VL testing. Median completion rate was 16% (n=479) at baseline (from March 2018 to February 2019) and rose to 73% (n=755) during the implementation period (from March 2019 to July 2020). In the final month (July 2020), rates rose to 90% (n=31). Another success was the increase in the proportion of clients whose VL was resuppressed on repeat testing, which improved from 34% (n=273) at baseline to 62% (n=710) during the implementation period and 77% (n=44) in the final month. The QIC also led to improvement in the proportion of AYPLWH on first-line ART whose regimens were switched within 2 months of recorded UVL results, which rose from 58% (n=48) at baseline to 94% (n=128) during the implementation period. In summary, the QIC helped facility teams to identify and prioritise local, contextually appropriate innovations which led to swift improvement in three critical indicators of VL utilisation.

Indexed as

HIV InfectionsAdolescentCounselingHealth FacilitiesHumansKenyaViral LoadCollaborative, breakthrough groupsContinuous quality improvementQuality improvementQuality improvement methodologiesTime-to-Treatment

Identifiers

PMID35948387
PMCPMC9379533

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.